| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/25/1992 | US5091185 Growth hormones with release inhibiting coating of hydrolysed polyvinyl alcohol |
| 02/25/1992 | US5091184 Coated adhesive tablets |
| 02/25/1992 | US5091175 Anticholesterol agents |
| 02/25/1992 | US5091171 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| 02/25/1992 | US5091111 Mixtures of a non-ionic surfactant, an alcohol, a polyhydroxy alcohol and/or polyhydroxy alcohol esters and a hydrocarbon propellant |
| 02/25/1992 | US5091064 Method for preparing perfluorinated heterocyclic compounds, and compounds prepared by this method |
| 02/25/1992 | CA1296459C Hydrogels with increased organic solvent soluble active agent loading capacity, their preparation and the use thereof |
| 02/25/1992 | CA1296254C Spheroids containing 3-alkylxanthine |
| 02/25/1992 | CA1296252C Method and composition for prophylaxis and treatment of viral infections |
| 02/25/1992 | CA1296176C Desiccant and dehydration therewith |
| 02/24/1992 | CA2049609A1 Low moisture chewing gum |
| 02/22/1992 | WO1992003380A1 Method for making uniformly-sized particles from insoluble compounds |
| 02/22/1992 | CA2089075A1 Method for making uniformly-sized particles from insoluble compounds |
| 02/21/1992 | WO1992003138A1 Improvements in or relating to organic compounds |
| 02/21/1992 | CA2065421A1 Organic compounds |
| 02/20/1992 | WO1992002560A1 Amphiphilic fluorine derivatives with telomeric structures; preparation and biomedical applications |
| 02/20/1992 | WO1992002243A1 Liposomes that provide thymic dependent help to weak vaccine antigens |
| 02/20/1992 | WO1992002234A2 Reduction or prevention of sensitization to drugs |
| 02/20/1992 | WO1992002226A1 Treatment for hypercholesterolemia |
| 02/20/1992 | WO1992002210A1 Polymers containing acetal, carboxy-acetal, ortho ester and carboxy-ortho ester linkages |
| 02/20/1992 | WO1992002209A1 Method for preparing a bioadhesive galenical and galenical thereby obtained |
| 02/20/1992 | WO1992002207A1 Oral pharmaceutical compositions containing melatonin |
| 02/20/1992 | WO1992002201A1 Device for energy-information exchange between objects |
| 02/20/1992 | DE4026153A1 Wundverband Wound dressing |
| 02/20/1992 | CA2088923A1 Amphiphilic fluorine derivatives with telomeric structures; preparation and biomedical applications |
| 02/19/1992 | EP0471618A1 Calcitonin-containing emulsion for nasal administration |
| 02/19/1992 | EP0471609A1 Benzofuran Derivatives, Benzothiophenes, Indoles or Indolizines, Process for Production and Compositions containing them |
| 02/19/1992 | EP0471558A2 Moisture barrier and its preparation |
| 02/19/1992 | EP0471309A1 Use of mixed micelles |
| 02/19/1992 | EP0471217A2 Composition for oral intake |
| 02/19/1992 | EP0471161A1 Spray container containing nitroglycerin in a hydrophilic aqueous composition |
| 02/19/1992 | EP0471100A1 Sustained release lithium carbonate tablets and method for preparing the same |
| 02/19/1992 | EP0471084A1 Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic |
| 02/19/1992 | EP0471036A1 Improved encapsulation process and products therefrom. |
| 02/19/1992 | EP0471009A1 Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
| 02/19/1992 | EP0418341A4 Percutaneous drug delivery system |
| 02/19/1992 | EP0269720B1 Induction of asymmetry in vesicles |
| 02/19/1992 | CN1058715A Solid oral forms of application containing ifosfamide as active substance |
| 02/18/1992 | US5089527 Pentamidine solutions |
| 02/18/1992 | US5089503 Aqueous alkaline solutions stored in vials with sodium phosphate washed rubber closures; nonsettling, injectable |
| 02/18/1992 | US5089482 Containing estradiol and/or progesterone; absorption |
| 02/18/1992 | US5089276 Calcium pantothenate composite |
| 02/18/1992 | US5089272 Process for producing capsules having a permeability-controllable membrane |
| 02/18/1992 | US5089271 Stabilized antibiotic compositions for animal feeding |
| 02/18/1992 | US5089270 Gelatin coated capsules |
| 02/18/1992 | US5089268 Enriched with omega-3 fatty acids |
| 02/18/1992 | US5089267 Treating Alzheimer*s |
| 02/18/1992 | US5089181 Flash evaporation, spray drying |
| 02/18/1992 | US5088505 Contraceptive implant |
| 02/18/1992 | US5088499 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
| 02/18/1992 | CA2049374A1 Use of mixed micelles |
| 02/18/1992 | CA2047969A1 Benzoporphyrin vesicles |
| 02/18/1992 | CA1295948C Perfluorohydrocarbons as vehicles for administering drugs |
| 02/18/1992 | CA1295946C Therapeutic agent containing tamoxifen for use in treatment of psoriasis |
| 02/18/1992 | CA1295942C Transdermal medicament |
| 02/18/1992 | CA1295941C Sustained-release formulation comprising a hydrophobic polymer system |
| 02/18/1992 | CA1295796C Biodegradable matrix and methods for producing same |
| 02/15/1992 | WO1992003125A1 Bone growth stimulator |
| 02/15/1992 | CA2049159A1 Moisture barrier and its preparation |
| 02/14/1992 | CA2088496A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 02/14/1992 | CA2048942A1 Composition for eye drops |
| 02/13/1992 | DE4122661A1 Prod. for treatment of Pneumocystis carinii pneumonia - consists of phospholipid-phospholipid charge carrier liposome system and pent:amidine |
| 02/13/1992 | DE4108903A1 Aq. liposome systems |
| 02/13/1992 | DE4108902A1 Aq. liposome systems |
| 02/12/1992 | EP0470872A1 Polysaccharide article and use thereof |
| 02/12/1992 | EP0470703A1 Thermally reversible and irreversible gels |
| 02/12/1992 | EP0470667A1 Composition containing a 4-quinolone derivative complexed with a divalent metal ion |
| 02/12/1992 | EP0470569A1 Intravascular embolizing agent containing angiogenesis inhibiting substance |
| 02/12/1992 | EP0470568A1 15-Deoxyspergualin suppository |
| 02/12/1992 | EP0470437A1 Aqueous liposome system |
| 02/12/1992 | EP0470251A1 Liquid prostaglandin composition |
| 02/12/1992 | EP0470246A1 Intralumenal drug eluting prosthesis. |
| 02/12/1992 | EP0470144A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours. |
| 02/12/1992 | CN1058612A Method for making health wine resisting cancer and senility |
| 02/12/1992 | CN1058534A Method for production of externally applied liquid to clean hair follicles |
| 02/12/1992 | CN1058533A Controlled release pharmaceutical preparation |
| 02/12/1992 | CN1058532A Process for preparing composition containing oral cephalosporin crystal hydrate |
| 02/11/1992 | US5087620 Controlled dermal penetration enhancement using imidazoles |
| 02/11/1992 | US5087455 Sustained drug delivery |
| 02/11/1992 | US5087454 Containing croscarmellose sodium and sodium lauryl sulfate; stable dissolution profile |
| 02/11/1992 | US5087447 Pharmaceutical preparations of high gastric acid binding capacity, delayed effect and of increased bioavailability |
| 02/11/1992 | US5087445 Sunscreen agents absorbing both the UVA and UVB wavelengths comprising a chromophoricester of benzophenone; daily use as a cosmetic |
| 02/11/1992 | US5087442 Containing iron citrate compound, sodium carbonate and/or bicarbonate, acid neutralizing agent |
| 02/11/1992 | US5086620 Method of microencapsulation of hyperbaric gas |
| 02/11/1992 | CA1295611C Association complex comprising pullulan and polyethylene glycol, and preparation and uses of the same |
| 02/11/1992 | CA1295516C Method to facilitate the formation of lipid spherical particles dispersedin a water phase, and to improve their stability and their encapsulation rate;and dispersion of same |
| 02/10/1992 | WO1992002223A1 Process for formulating a solid oral dosage form of loperamide compounds |
| 02/10/1992 | WO1992002211A1 Multiple drug delivery system |
| 02/10/1992 | CA2088982A1 Multiple drug delivery system |
| 02/09/1992 | WO1992002208A1 Stable doxorubicin/liposome composition |
| 02/09/1992 | CA2088975A1 Stable doxorubicin/liposome composition |
| 02/08/1992 | WO1992002212A2 Use of interfacially-polymerized membranes in delivery devices |
| 02/08/1992 | CA2022817A1 Polymers containing acetal, carboxy-acetal, ortho ester and carboxy-ortho ester linkages |
| 02/06/1992 | WO1992001466A1 Prophylactic and therapeutic applications of peroxidases |
| 02/06/1992 | WO1992001463A1 Stabilized somatotropin for parenteral administration |
| 02/06/1992 | WO1992001457A1 Products and processes for the treatment of the alimentary canal |
| 02/06/1992 | WO1992001453A1 Solid preparation |
| 02/06/1992 | WO1992001452A1 Enzyme inactivators |
| 02/06/1992 | WO1992001446A1 Sustained-release formulations |
| 02/06/1992 | WO1992001445A1 Oral osmotic device for delivering nicotine |